(Q38787215)

6 September 2017

title

Adjuvant chemotherapy in elderly patients with breast cancer: key challenges (English)

1 reference

6 September 2017

Noam Pondé

1

1 reference

6 September 2017

Lissandra Dal Lago

series ordinal

2

1 reference

6 September 2017

Hatem A Azim

series ordinal

3

1 reference

6 September 2017

publication date

24 March 2016

1 reference

Expert Review of Anticancer Therapy

6 September 2017

published in

1 reference

6 September 2017

volume

16

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

661-671

1 reference

The elderly patient with cancer: a holistic view

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Improvement in breast cancer outcomes over time: are older women missing out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Lack of survival gain for elderly women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Difficulties in decision making regarding chemotherapy for older cancer patients: A census of cancer physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Geriatric oncology, general practitioners and specialists: current opinions and unmet needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Adjuvant chemotherapy in older women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Research priorities in geriatric oncology: addressing the needs of an aging population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Provider roles in the recruitment of underrepresented populations to cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Hearing loss and dementia - who is listening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Effect of depression on diagnosis, treatment, and survival of older women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Ageing, remembering, and executive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

How to implement a geriatric assessment in your clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Treatment for breast cancer in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Clinical practice. Depression in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Cancer information disclosure in different cultural contexts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

A systematic review of factors influencing older adults' decision to accept or decline cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Psychosocial determinants and outcomes of chemotherapy in older women with breast cancer: what do we know? What do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Older people with cancer: perceptions and feelings about information, decision-making and treatment--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Early primary breast cancer in the elderly - pattern of presentation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

An update on a systematic review of the use of geriatric assessment for older adults in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Use of geriatric assessment for older adults in the oncology setting: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

The influence of comorbidities on overall survival among older women diagnosed with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

The central role of prognosis in clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Prognostic indices for older adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Predicting 10-year mortality for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Assessment and management of falls in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Polypharmacy in the elderly: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

The challenge of managing drug interactions in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Polypharmacy in elderly patients with cancer: clinical implications and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Malnutrition in the elderly: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Functional decline and recovery of activities of daily living in hospitalized, disabled older women: the Women's Health and Aging Study I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Functional decline in older adults one year after hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Supportive care considerations for older adults with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Late effects of adjuvant chemotherapy for breast cancer on fine motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Breast cancer therapy-associated cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Cardiac effects of anticancer therapy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2016.1170595

10.1586/14737140.2016.1170595

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference